Attributable Risk And Specific Causation

Law360, New York (November 10, 2008, 12:00 AM ET) -- The plaintiff in a pharmaceutical products liability or toxic tort case must prove by a preponderance of the evidence that the drug or other substance more likely than not caused or contributed to his alleged injury.

Proving causation in such cases typically involves a two-step process: the plaintiff first must prove that the substance is capable of causing the type of harm alleged (i.e., general causation) and then must prove that his particular exposure to it in fact caused his alleged injury (i.e., specific causation)....
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles